Page last updated: 2024-10-30

leflunomide and Brain Diseases

leflunomide has been researched along with Brain Diseases in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Didier, PJ1
Adrián, ML1
Paola, SA1
Mauricio, FS1
Omar, CS1
Liset, RY1
Luis, RJ1

Other Studies

1 other study available for leflunomide and Brain Diseases

ArticleYear
CLIPPERS syndrome responsive to Leflunomide: A case report.
    Multiple sclerosis and related disorders, 2018, Volume: 25

    Topics: Adult; Brain Diseases; Cerebellum; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammation

2018